SCHEMBL3219472

SCHEMBL3219472

FC(F)(F)C(F)(F)C(F)(F)C1(C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3221624 0.92
SCHEMBL4453986 0.88
SCHEMBL3215527 0.83
SCHEMBL7043871 0.83
SCHEMBL4954124 0.82
SCHEMBL1280066 0.75 MEN1 (0.33)
SCHEMBL149623 0.75 MEN1 (0.33)
SCHEMBL6885374 0.75 MEN1 (0.33)
SCHEMBL555524 0.75 MEN1 (0.33)
SCHEMBL297814 0.75 MEN1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0033402-B1 PERFUSATE FOR PRESERVING ORGAN TO BE TRANSPLANTED AND PRESERVING METHOD The Green Cross Corporation (JP) 1983-09-07 EP claimed
EP-0033402-A1 Perfusate for preserving organ to be transplanted and preserving method The Green Cross Corporation (JP) 1981-08-12 EP claimed
US-4186253-A RINGER'S SOLUTION WITH INCREASED POTASSIUM ION, ALBUMIN, PERFLUOROCARBON COMPOUND, EMULSIFIER THE GREEN CROSS CORPORATION (JP) 1980-01-29 US claimed
US-3962439-A PERFLUOROCARBON COMPOUNDS THE GREEN CROSS CORPORATION (JA) 1976-06-08 US claimed
CN-116539738-A Method for measuring immobilized amount of fat-soluble vitamin 旭化成医疗株式会社 2023-08-04 CN disclosed
EP-2198869-B1 TREHALOSE FOR THE TREATMENT OR PREVENTION OF VASOSPASM NEXT 21 K K (JP) 2015-09-16 EP disclosed
US-8283337-B2 Therapeutic or prophylactic agent for vasoconstriction NEXT21 K.K. (JP) 2012-10-09 US disclosed
EP-2198869-A1 THERAPEUTIC OR PROPHYLACTIC AGENT FOR VASOCONSTRICTION Next 21 K.K. (JP) 2010-06-23 EP disclosed
US-20100035837-A1 THERAPEUTIC OR PROPHYLACTIC AGENT FOR VASOCONSTRICTION NEXT21 K.K. (JP) 2010-02-11 US disclosed
EP-0923955-B1 Manufacturing method of artificial organ, hollow fiber membrane, and dialyzer of hollow fiber membrane type ASAHI KASEI KURARAY MEDICAL CO (JP) 2008-06-18 EP disclosed
EP-0749775-B1 Method for production of hollow-fiber membrane, hollow-fiber membrane, and dialyzer ASAHI MEDICAL CO (JP) 2003-08-13 EP disclosed
EP-1295602-A1 OXYGEN-CONTAINING OPHTHALMIC COMPOSITION ROHTO PHARMACEUTICAL CO., LTD. (JP) 2003-03-26 EP disclosed
WO-1992022202-A1 THROMBOLYTIC AND PERFLUOROCHEMICAL TREATMENT FOR MYOCARDIAL INFRACTION ALPHA THERAPEUTICS CORPORATION (US) 1992-12-23 WO disclosed
EP-0220153-B1 A NUTRITIVE EMULSION HAVING OXYGEN-TRANSPORTING PROPERTIES, AND PROCESS FOR ITS PREPARATION Kabi Pharmacia AB (SE) 1991-07-24 EP disclosed
US-4815446-A ADMINISTERING PERFLUOROCARBON EMULSION AND OXYGEN ALPHA THERAPEUTIC CORPORATION (US) 1989-03-28 US disclosed
EP-0220153-A1 A nutritive emulsion having oxygen-transporting properties, and process for its preparation Kabi Pharmacia AB (SE) 1987-04-29 EP disclosed
EP-0033402-B1 PERFUSATE FOR PRESERVING ORGAN TO BE TRANSPLANTED AND PRESERVING METHOD The Green Cross Corporation (JP) 1983-09-07 EP disclosed
EP-0033402-A1 Perfusate for preserving organ to be transplanted and preserving method The Green Cross Corporation (JP) 1981-08-12 EP disclosed
US-4252827-A PERFLUORODECALIN AND PERFLUOROTRIPROPYLAMINE; ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER; PHOSPHOLIPID; FATTY ACID, SALT OR MONOGLYCERIDE THE GREEN CROSS CORPORATION (JP) 1981-02-24 US disclosed
US-4186253-A RINGER'S SOLUTION WITH INCREASED POTASSIUM ION, ALBUMIN, PERFLUOROCARBON COMPOUND, EMULSIFIER THE GREEN CROSS CORPORATION (JP) 1980-01-29 US disclosed